A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 (a Fibrin Derived Peptide Bbeta15-42) on Ischemia Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI): The `F.I.R.E.' Study
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs FX 06 (Primary)
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Therapeutic Use
- Acronyms FIRE
- 06 Nov 2012 Planned number of patients changed from 140 to 220 as reported by European Clinical Trials Database record.
- 31 Mar 2009 Results of a prespecified subgroup analysis investigating effects of time to therapy were presented at the American College of Cardiology (ACC-2009).
- 24 Feb 2009 Results are published in Journal of the American College of Cardiology 53: 720-729, No. 8, 24 Feb 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History